Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation,

Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price

Micron, Sandisk and Nvidia lead seven S&P 500 stocks that more than doubled quarterly revenue. S

The S&P 500 hit a record high Tuesday, but only 15 of its 504 stocks did too. The median member

Shares of Waters Corporation (NYSE: WAT - Get Free Report) hit a new 52-week high during trading on

Guggenheim analyst Subbu Nambi maintains Waters (NYSE:WAT) with a Buy and raises the price target

MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2026 fi

Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.95% on an annualized basis

Waters NYSE: WAT President and Chief Executive Officer Udit Batra said the company's second-quarter

Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript

A grand total of zero monthly or quarterly economic reports have come out so far this week.

Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ra

Goldman Sachs analyst Evie Koslosky maintains Waters (NYSE:WAT) with a Buy and raises the price t

WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced a partnershi

Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.59% on an annualized basis

Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising

MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Ba

Analysts upgraded SFNC, OBIO, and more.

Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and i

UBS analyst Doug Schenkel upgrades Waters (NYSE:WAT) from Neutral to Buy and raises the price tar

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Benjamin Edwards Inc. lifted its holdings in shares of Waters Corporation (NYSE: WAT) by 72.5% in th

Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.82% on an annualized basis

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Top Wall Street analysts upgraded BWX Technologies, The Macerich Company, and Waters Corporation. Ch

Piper Sandler analyst David Westenberg upgrades Waters (NYSE:WAT) from Neutral to Overweight and

WEST CHESTER, Ohio--(BUSINESS WIRE)--LetsGetChecked now offers the most comprehensive FDA-cleared at

MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Bat

Bank of Nova Scotia cut its stake in shares of Waters Corporation (NYSE: WAT) by 27.3% in the second

Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the se

Assetmark Inc. lowered its holdings in Waters Corporation (NYSE: WAT) by 56.5% in the second quarter

Citigroup analyst Joanne Wuensch maintains Waters (NYSE:WAT) with a Buy and raises the price targ

Dudley and Shanley Inc. raised its holdings in Waters Corporation (NYSE: WAT) by 101.3% in the secon

TD Cowen analyst Dan Brennan upgrades Waters (NYSE:WAT) from Hold to Buy and raises the price tar

RBC Capital analyst Dan Leonard maintains Waters (NYSE:WAT) with a Outperform and raises the pric

Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a Outperform and raises t

Wells Fargo analyst Evan Stampler maintains Waters (NYSE:WAT) with a Equal-Weight and raises the

Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price

Waters (NYSE:WAT) is looking for Q3 Adj EPS of $3.95-$4.05 vs $3.99 analyst estimate. sees sales of

Waters (NYSE:WAT) raises FY2026 Adj EPS guidance from $14.40-$14.60 to $14.45-$14.65 vs $14.51 analy

Waters (NYSE:WAT) reported quarterly earnings of $3.05 per share which beat the analyst consensus es

Goldman Sachs analyst Patrick Donnelly maintains Waters (NYSE:WAT) with a Buy and raises the pric

Morgan Stanley analyst Kallum Titchmarsh maintains Waters (NYSE:WAT) with a Equal-Weight and rais

RBC Capital analyst Dan Leonard initiates coverage on Waters (NYSE:WAT) with a Outperform rating

Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a Outperform and raises t

Piper Sandler analyst David Westenberg initiates coverage on Waters (NYSE:WAT) with a Neutral rat

FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader acce